Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28279631 | 0.88 | TDP1 (0.37) | TDP1ALDH1A1FFAR3TSHR | |
| SCHEMBL2546877 | 0.82 | ALDH1A1 (0.41) | TDP1ALDH1A1FFAR3TSHR | |
| SCHEMBL16341856 | 0.79 | CES2 (0.39) | ALDH1A1FFAR3TSHR | |
| SCHEMBL26125123 | 0.79 | TDP1 (0.30) | TDP1ALDH1A1FFAR3TSHR | |
| SCHEMBL43655 | 0.76 | — | — | |
| SCHEMBL2784326 | 0.76 | — | — | |
| SCHEMBL7752906 | 0.76 | ALDH1A1 (0.41) | TDP1ALDH1A1FFAR3TSHR | |
| SCHEMBL8460820 | 0.75 | TP53 (0.35) | TDP1ALDH1A1TSHR | |
| SCHEMBL14643904 | 0.74 | — | — | |
| SCHEMBL7965201 | 0.74 | TDP1 (0.35) | TDP1ALDH1A1FFAR3TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662282-A1 | DRIER AND ANTI-SKINNING AGENT SYSTEM FOR A COATING COMPOSITION | PPG Europe B.V. (NL) | 2025-12-17 | — | — | EP | claimed |
| EP-4414430-A9 | DRIER AND ANTI-SKINNING AGENT SYSTEM FOR A COATING COMPOSITION | PPG Europe B.V. (NL) | 2024-11-20 | — | — | EP | claimed |
| WO-2024165699-A1 | DRIER AND ANTI-SKINNING AGENT SYSTEM FOR A COATING COMPOSITION | PPG EUROPE B.V. (NL) | 2024-08-15 | — | — | WO | claimed |
| EP-4414430-A1 | DRIER AND ANTI-SKINNING AGENT SYSTEM FOR A COATING COMPOSITION | PPG Europe B.V. (NL) | 2024-08-14 | — | — | EP | claimed |
| EP-4662282-A1 | DRIER AND ANTI-SKINNING AGENT SYSTEM FOR A COATING COMPOSITION | PPG Europe B.V. (NL) | 2025-12-17 | — | — | EP | disclosed |
| US-20250302727-A1 | COSMETIC USE OF A COMBINATION OF IMMORTELLE EXTRACTS TO REDUCE THE VISIBILITY OF SKIN PORES | LABORATOIRES M&L (FR) | 2025-10-02 | — | — | US | disclosed |
| EP-4414430-A9 | DRIER AND ANTI-SKINNING AGENT SYSTEM FOR A COATING COMPOSITION | PPG Europe B.V. (NL) | 2024-11-20 | — | — | EP | disclosed |
| CN-118871084-A | Cosmetic use of a combination of non-apoptotic flower extracts for reducing the visibility of skin pores | M&L实验室 | 2024-10-29 | — | — | CN | disclosed |
| WO-2024165699-A1 | DRIER AND ANTI-SKINNING AGENT SYSTEM FOR A COATING COMPOSITION | PPG EUROPE B.V. (NL) | 2024-08-15 | — | — | WO | disclosed |
| EP-4414430-A1 | DRIER AND ANTI-SKINNING AGENT SYSTEM FOR A COATING COMPOSITION | PPG Europe B.V. (NL) | 2024-08-14 | — | — | EP | disclosed |
| WO-2023180126-A1 | COSMETIC USE OF A COMBINATION OF IMMORTELLE EXTRACTS TO REDUCE THE VISIBILITY OF SKIN PORES | LABORATOIRES M&L (FR) | 2023-09-28 | — | — | WO | disclosed |
| US-20110166132-A1 | Gamma Secretase Modulators | AMGEN INC. (US) | 2011-07-07 | — | — | US | disclosed |
| EP-2231602-A1 | GAMMA SECRETASE MODULATORS | Amgen, Inc (US) | 2010-09-29 | — | — | EP | disclosed |
| EP-2184061-A1 | Genariol as bacterial efflux pump inhibitor | Universite de Corse (FR) | 2010-05-12 | — | — | EP | disclosed |
| WO-2009075874-A1 | GAMMA SECRETASE MODULATORS | AMGEN INC. (US) | 2009-06-18 | — | — | WO | disclosed |
| US-4051229-A | REDUCTION OF ALKALI OR ALKALINE EARTH CHLORATE IN SULFURIC OR HYDROCHLORIC ACID WITH COMPLEX B-DIKETONE-PALLADIUM CATALYST | THE JAPAN CARLIT CO., LTD. (JA) | 1977-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250302727-A1 | COSMETIC USE OF A COMBINATION OF IMMORTELLE EXTRACTS TO REDUCE THE VISIBILITY OF SKIN PORES | CUTA, IMMT, SYMPK | TDP1 3366/4885ALDH1A1 4767/4885FFAR3 2257/4885 |
| US-20110166132-A1 | Gamma Secretase Modulators | BACE1, BACE2, PSEN1 | TDP1 782/4885ALDH1A1 3262/4885FFAR3 3761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.